Good symptom relief with palliative MVP (mitomycin-C, vinblastine and cisplatin) chemotherapy in malignant mesothelioma
Open Access
- 1 March 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (3) , 269-273
- https://doi.org/10.1023/a:1008236010868
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Chemotherapy in malignant pleural mesothelioma. A review.Journal of Clinical Oncology, 1996
- A Proposed New International TNM Staging System for Malignant Pleural MesotheliomaChest, 1995
- Symptom relief with MVP (mitomycin C, vinblastine and cisplatin) chemotherapy in advanced non-small-cell lung cancerBritish Journal of Cancer, 1995
- A phase II evaluation of ifosfamide and mesna in unresectable diffuse malignant mesothelioma: A southwest oncology group studyCancer, 1992
- The role of extrapleural pneumonectomy in malignant pleural mesotheliomaThe Journal of Thoracic and Cardiovascular Surgery, 1991
- Chemotherapy in malignant mesothelioma: a reviewCancer Chemotherapy and Pharmacology, 1991
- Malignant Pleural Mesothelioma: Phase II Pilot Study of Ifosfamide and Mesna*JNCI Journal of the National Cancer Institute, 1988
- Reporting results of cancer treatmentCancer, 1981
- Prediction of Creatinine Clearance from Serum CreatinineNephron, 1976
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958